StageZero Life Sciences Ltd. (SZLSF)

OTCMKTS · Delayed Price · Currency is USD
0.0240
-0.0024 (-9.27%)
Jun 25, 2025, 3:14 PM EDT

StageZero Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022 FY 2021 FY 2020 FY 2019 FY 2018 2013 - 2017
Period Ending
Jun '25 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 2013 - 2017
45213695
Upgrade
Market Cap Growth
-15.50%-78.12%-42.45%312.71%82.87%-74.78%
Upgrade
Enterprise Value
562037128
Upgrade
Last Close Price
0.020.040.230.580.230.30
Upgrade
PS Ratio
1.261.194.068.6162.4325.48
Upgrade
PB Ratio
-0.40-0.607.45-28.97-1.93-0.86
Upgrade
EV/Sales Ratio
1.731.644.029.0183.1043.76
Upgrade
Debt / Equity Ratio
-0.15-0.240.49-2.89-0.55-0.52
Upgrade
Asset Turnover
0.650.670.530.790.080.09
Upgrade
Inventory Turnover
21.8616.6510.1915.6111.0711.11
Upgrade
Quick Ratio
0.010.010.391.220.060.03
Upgrade
Current Ratio
0.040.040.501.300.090.06
Upgrade
Return on Equity (ROE)
---979.39%---
Upgrade
Return on Assets (ROA)
-63.79%-85.34%-51.97%-44.60%-181.32%-140.91%
Upgrade
Return on Capital (ROIC)
---154.21%-1531.05%--
Upgrade
Earnings Yield
-344.52%-253.61%-36.39%-19.21%-40.21%-77.98%
Upgrade
FCF Yield
--78.40%-44.26%-8.78%-53.53%-73.15%
Upgrade
Buyback Yield / Dilution
-32.99%-40.60%-57.77%-69.14%-54.89%-41.63%
Upgrade
Updated Dec 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.